New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
- OPACC
- Jan 12, 2023
- 1 min read
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study findings showed.
Commentaires